Prostate MRI explained
A prostate MRI shows whether there is actually a suspicious area in the prostate, where it is and how big the prostate is. It has changed how urologists decide who needs a biopsy and where to take it.
What the scan is
A multiparametric MRI combines several types of images of the prostate: one showing its anatomy, one showing how freely water moves through the tissue (cancer restricts it), and often one showing blood flow after a contrast injection.
The standard is a 3 Tesla (3T) multiparametric MRI, the most detailed type, read by a radiologist experienced in prostate imaging. Image quality and reader experience matter as much as the scanner.
A shorter, non-contrast (biparametric) MRI skips the contrast injection. It is faster and costs less, and it works well as a screening tool for men with a raised PSA who haven't had a biopsy. Contrast is still useful after a prior negative biopsy, during active surveillance, after treatment or when images are hard to read.
- It takes about 30 to 45 minutes, lying on your back in the scanner.
- There is no radiation.
- Some centers ask you to avoid ejaculation for a few days, use an enema or take a medicine to reduce bowel motion, so the images are sharper.
- Tell the center if you have a pacemaker, defibrillator, other implanted device, metal fragments, a hip replacement, kidney disease or claustrophobia.
Your PI-RADS score
The radiologist scores the most suspicious area from 1 to 5 using the Prostate Imaging–Reporting and Data System (PI-RADS, version 2.1). It describes how likely that area is to be significant cancer (Grade Group 2 or higher):
| PI-RADS | Meaning | Men with significant cancer |
|---|---|---|
| 1 | Very low suspicion | About 6 in 100 |
| 2 | Low suspicion | About 9 in 100 |
| 3 | Equivocal (could go either way) | About 16 in 100 |
| 4 | High suspicion | About 59 in 100 |
| 5 | Very high suspicion | About 85 in 100 |
Patient-level detection rates from a meta-analysis by Oerther et al., Prostate Cancer Prostatic Dis 2022. Rates vary between centers and radiologists.
PI-RADS 3 is the hardest result. Most men with a PI-RADS 3 area do not have significant cancer, so urologists often use PSA density, the PSA trend or a blood or urine test to decide between biopsy and monitoring.
Why prostate volume matters
The MRI report also gives the prostate's size in cubic centimeters (cc) or milliliters. A normal adult prostate is roughly 20 to 30 cc, and many men over 60 have larger ones. A bigger prostate makes more PSA without any cancer.
PSA density corrects for this: it is your PSA divided by your prostate volume. A density of 0.15 or higher raises concern, and below 0.10 is reassuring. A PSA of 6 means something very different in a 25 cc prostate (density 0.24) than in a 75 cc prostate (density 0.08).
On mypsalevel, entering both your PI-RADS score and your prostate volume lets the calculator use the PLUM model, which was built on men who had an MRI before biopsy. Without the volume, the MRI can't be included in the estimate. Why MRI changes the numbers
How MRI changes the biopsy
- Fewer unnecessary biopsies. In the PRECISION trial, about 28 in 100 men whose MRI showed no suspicious area avoided a biopsy (Kasivisvanathan et al., NEJM 2018).
- Better aim. MRI-targeted biopsy found significant cancer in 38% of men, versus 26% with the older standard biopsy, while finding less low-grade cancer that didn't need treatment (9% versus 22%).
- Targeted plus systematic. Many urologists now sample the MRI target plus a standard pattern of the rest of the prostate, often using software that fuses the MRI with live ultrasound.
- Transperineal approach. More biopsies are now done through the skin between the scrotum and anus rather than through the rectum, which carries a much lower risk of infection.
A normal MRI makes significant cancer much less likely, but doesn't rule it out completely. If your PSA keeps rising or your PSA density is high, your urologist may still recommend a biopsy or a repeat MRI.
Add my MRI to the calculator